...
首页> 外文期刊>BMC Pediatrics >GRIN: “GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: an assessor-masked randomised comparison trial”: study protocol
【24h】

GRIN: “GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: an assessor-masked randomised comparison trial”: study protocol

机译:GRIN:“针对流动性脑瘫患儿注射下肢肌肉肉毒杆菌毒素-A后的GRoup与个体理疗:评估者掩盖的随机比较试验”:研究方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Cerebral palsy is the most common cause of physical disability in childhood. Spasticity is a significant contributor to the secondary impairments impacting functional performance and participation. The most common lower limb spasticity management is focal intramuscular injections of Botulinum Toxin-Type A accompanied by individually-delivered (one on one) physiotherapy rehabilitation. With increasing emphasis on improving goal-directed functional activity and participation within a family-centred framework, it is timely to explore whether physiotherapy provided in a group could achieve comparable outcomes, encouraging providers to offer flexible models of physiotherapy delivery. This study aims to compare individual to group-based physiotherapy following intramuscular Botulinum Toxin-A injections to the lower limbs for ambulant children with cerebral palsy aged four to fourteen years. Methods/Design An assessor-masked, block randomised comparison trial will be conducted with random allocation to either group-based or individual physiotherapy. A sample size of 30 (15 in each study arm) will be recruited. Both groups will receive six hours of direct therapy following Botulinum Toxin-A injections in either an individual or group format with additional home programme activities (three exercises to be performed three times a week). Study groups will be compared at baseline (T1), then at 10 weeks (T2, efficacy) and 26 weeks (T3, retention) post Botulinum Toxin-A injections. Primary outcomes will be caregiver/s perception of and satisfaction with their child’s occupational performance goals (Canadian Occupational Performance Measure) and quality of gait (Edinburgh Visual Gait Score) with a range of secondary outcomes across domains of the International Classification of Disability, Functioning and Health. Discussion This paper outlines the study protocol including theoretical basis, study hypotheses and outcome measures for this assessor-masked, randomised comparison trial comparing group versus individual models of physiotherapy following intramuscular injections of Botulinum Toxin-A to the lower limbs for ambulant children with cerebral palsy. Trial registration ACTRN12611000454976
机译:背景脑瘫是儿童期肢体残疾的最常见原因。痉挛是影响功能表现和参与的继发性损伤的重要因素。最常见的下肢痉挛管理是局部肌肉注射A型肉毒杆菌毒素,并伴有单独进行的(一对一)理疗康复。随着越来越重视改善以目标为导向的功能活动和在以家庭为中心的框架内的参与,现在应该探讨在一个小组中提供的物理治疗是否可以实现可比较的结果,从而鼓励提供者提供灵活的物理治疗交付模式。这项研究的目的是比较四到十四岁的患有脑瘫的流动儿童的肌肉注射肉毒杆菌毒素-A后下肢的个人疗法和团体疗法。方法/设计将进行评估者掩盖的,分组的随机比较试验,并随机分配给基于小组的治疗或单独的物理治疗。样本量为30(每个研究组15个)。两组都将接受个人或团体形式的肉毒杆菌毒素A注射后六个小时的直接治疗,并进行额外的家庭计划活动(每周进行三次,每次三次)。将在注射肉毒杆菌毒素A后的基线(T1),10周(T2,功效)和26周(T3,保留)时比较研究组。主要结果将是照料者对孩子的职业绩效目标(加拿大职业绩效指标)和步态质量(爱丁堡视觉步态得分)的理解和满意度,以及国际残疾,功能和性行为分类的各个范围的次级结果。健康。讨论本文概述了该评估者掩盖的,随机对照试验的研究方案,包括理论基础,研究假设和结果测量,该试验比较了成年轻瘫儿童下肢肌肉内注射肉毒杆菌毒素A后的理疗组与个体理疗模型。试用注册ACTRN12611000454976

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号